KR880002521A - 약제 제형 - Google Patents

약제 제형 Download PDF

Info

Publication number
KR880002521A
KR880002521A KR1019870008807A KR870008807A KR880002521A KR 880002521 A KR880002521 A KR 880002521A KR 1019870008807 A KR1019870008807 A KR 1019870008807A KR 870008807 A KR870008807 A KR 870008807A KR 880002521 A KR880002521 A KR 880002521A
Authority
KR
South Korea
Prior art keywords
pharmaceutical formulation
ace
inhibitor
physiologically acceptable
acceptable salt
Prior art date
Application number
KR1019870008807A
Other languages
English (en)
Inventor
요나스 로흐스
좀브로에크 요아네스
클록코프 미카엘
Original Assignee
노우만, 헤우만
메르코 파텐트 게젤샤프트 미트 베슈랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노우만, 헤우만, 메르코 파텐트 게젤샤프트 미트 베슈랭크터 하프퉁 filed Critical 노우만, 헤우만
Publication of KR880002521A publication Critical patent/KR880002521A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

약제 제형
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 양성근 변력 작용을 갖는 적어도 하나의 이미다조 피리딘 및/또는 적어도 하나의 그의 생리학적으로 허용될 수 있는 염 및 적어도 하나의 ACE-저해제를 함유한 약제 제형.
  2. 이소마졸 및/또는 그의 생리학적으로 허용될 수 있는 염의 하나와 적어도 하나의 ACE-저해제를 함유하는 약제 제형
  3. 양성 근 변력작용을 갖는 적어도 하나의 이미다조피리딘 및/또는 적어도 하나의 생리학적으로 허용될 수 있는 염을 적어도 하나의 ACE-저해제 및 적어도 하나의 부형제 또는 보조제와 함께 적합한 투여형태로 전환시키는 것을 특징으로 하는 약제 제형의 제조방법.
  4. 양성 근 변력 작용을 갖는 적어도 하나의 이미다조피리딘 및/또는 적어도 하나의 그의 생리학적으로 허용될수 있는 염 및 적어도 하나의 ACE-저해제를 함유하는 약제 제형의 심질환 치유에의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870008807A 1986-08-14 1987-08-11 약제 제형 KR880002521A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863627613 DE3627613A1 (de) 1986-08-14 1986-08-14 Pharmazeutische zubereitung
DEP3627613.8 1986-08-14

Publications (1)

Publication Number Publication Date
KR880002521A true KR880002521A (ko) 1988-05-09

Family

ID=6307397

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870008807A KR880002521A (ko) 1986-08-14 1987-08-11 약제 제형

Country Status (5)

Country Link
EP (1) EP0256402A3 (ko)
KR (1) KR880002521A (ko)
AR (1) AR241574A1 (ko)
DE (1) DE3627613A1 (ko)
ZA (1) ZA876048B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
CA2021408A1 (en) * 1989-08-31 1991-03-01 Luana R. C. Moore Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3139064A1 (de) * 1981-10-01 1983-04-14 Merck Patent Gmbh, 6100 Darmstadt 2-aryl-imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ZA876048B (en) 1988-04-27
EP0256402A3 (de) 1989-09-20
DE3627613A1 (de) 1988-02-18
EP0256402A2 (de) 1988-02-24
AR241574A1 (es) 1992-09-30

Similar Documents

Publication Publication Date Title
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
MX9203543A (es) Medicamento.
ES2072447T3 (es) Locion analgesica externa y procedimiento de preparacion.
FR2613619B1 (fr) Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
NO177376C (no) Fremgangsmåte for fremstilling av en farmasöytisk doseringsform basert på en tampongtrykkmetode
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
SE8505569D0 (sv) Enteralt preparat
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
SE8500996D0 (sv) Method of treatment
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
DE3764111D1 (de) Arzneimittelkombination.
KR880002521A (ko) 약제 제형
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
ITRM910435A0 (it) Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
KR890007728A (ko) 진통제 제조방법
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
KR900017599A (ko) 종양 치료용 약학 조성물
FR2605008B1 (fr) Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique
Drâgan et al. Studies on selenium in top athletes
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
FR2606409B1 (fr) Derives d'imidazopyridine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid